Mastering chemotherapy dose reduction in elderly cancer patients
- 31 October 2007
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 43 (15), 2235-2241
- https://doi.org/10.1016/j.ejca.2007.06.013
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 updateEuropean Journal Of Cancer, 2007
- International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiencyEuropean Journal Of Cancer, 2007
- EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumoursEuropean Journal Of Cancer, 2006
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Use of comprehensive geriatric assessment in older cancer patients:Critical Reviews in Oncology/Hematology, 2005
- Can older cancer patients tolerate chemotherapy?Cancer, 2003
- Pharmacology of Anticancer Drugs in the Elderly PopulationClinical Pharmacokinetics, 2003
- Pharmacokinetic Drug Interactions with Anticancer DrugsClinical Pharmacokinetics, 1994
- Pharmacokinetic Drug Interactions of Commonly Used Anticancer DrugsClinical Pharmacokinetics, 1986
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981